Krystal Biotech KRYS has outperformed the market over the past 5 years by 18.9% on an annualized basis producing an average annual return of 32.47%. Currently, Krystal Biotech has a market capitalization of $5.01 billion.
Buying $100 In KRYS: If an investor had bought $100 of KRYS stock 5 years ago, it would be worth $401.85 today based on a price of $175.53 for KRYS at the time of writing.
Krystal Biotech’s Performance Over Last 5 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.